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Constipation is a common functional gastrointestinal disor-
der which has caused much discomfort affecting the quality
of life. The prevalence of constipation in the general popula-
tion is approximately 20% [1]. Various kinds of laxatives were
introduced such as bulking agent, stool softener, stimulant, and
osmotic agent [2]. Fixed dose combination with bisacodyl as
a stimulant and docusate sodium as a stool softener, Ducolax
STM, was developed as enteric coated tablets targeting colon.
Hydrophilic polymers have the ability to absorb a large amount
of water in the gastrointestinal tract, which has been re-
ported to be useful to treat constipation [3]. We focus on the
possible synergic effect of hydrophilic polymer with bisacodyl.
The aim of this study was to develop enteric coated triple-
layered tablet formulation containing bisacodyl and docusate
sodium with hydrophilic polymer and investigate the syner-
gistic effect by loperamide-induced constipation model in rat.
Sodium carboxymethylcellulose was selected among hy-
drophilic polymers. Bi-layered and triple-layered tablet
formulations were prepared because hydrophilic polymer nega-
tively affects the dissolution profiles of bisacodyl and docusate
sodium.Tablets were enteric coated using an aqueous disper-
sion of Acryl-Eze IITM to ensure the gastric resistance and drug
delivery to the colon region. In vitro drug dissolution test was
conducted according to USP Apparatus 2 at 100 rpm in pH 7.5
phosphate buffer after an acid stage in 0.1 N hydrochloride for
2 hours and analyzed the released drug using reversed phase
HPLC at a wavelength of 210 nm. In loperamide-induced con-
stipation model rat, the synergistic effect of sodium
carboxymethylcellulose with bisacodyl was evaluated by check-
ing the change of stool weight.The bi- and triple-layered tablets
were successfully manufactured without any troubles during
the tableting process. The bi-layered tablets induced the criti-
cal problem related to stability because bisacodyl is easily
hydrolyzed upon contact with sodium carboxymethylcellu-
lose, while triple-layered tablets with inactive middle layer
drastically improved the stability. Enteric coating with an
aqueous dispersion of AcrylEze IITM showed acceptable acid re-
sistance in 0.1 N HCl and pH 4.5 acetate buffer for 2 hours,
although some of the marketed products failed in pH 4.5.Triple-
layered prototype indicated comparable acid resistance and
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dissolution profile with Ducolax STM (Fig. 1). Sodium carboxy-
methylcellulose co-administrated with bisacodyl increased the
weight of stools in loperamide-induced constipation model rats
in comparison with bisacodyl administrated group showing the
synergistic effect.
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Fig. 1 – Comparative dissolution profiles of prototype and Ducolax STM.
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